Evidence map›Paper›PMID 36001137›Full record

ArticleWorld journal of urology2022

An ex-vivo assessment of a new single probe triple modality (Trilogy) lithotripter.

Charles Joseph O'Connor, Donnacha Hogan, Lee Chien Yap, Louise Lyons, Derek Barry Hennessey

Open access · hybridAbstract read
In one paragraph

Article in World journal of urology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.3field-weighted citation impact, top 41% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 2 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Charles Joseph O'ConnorDepartment of Urology, Mercy University Hospital, Cork, Ireland. mrcharlesoconnor@gmail.com.ORCID http://orcid.org/0000-0002-9028-5569
Donnacha HoganDepartment of Urology, Mercy University Hospital, Cork, Ireland.
Lee Chien YapDepartment of Urology, Mercy University Hospital, Cork, Ireland.
Louise LyonsDepartment of Urology, Mercy University Hospital, Cork, Ireland.
Derek Barry HennesseyDepartment of Urology, Mercy University Hospital, Cork, Ireland.
Mercy University Hospital · IE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

INTRODUCTION AND

objectivesThis Swiss LithoClast MATERIALS AND

methodsKidney stone phantoms were made with Begostone in a powder to water ratio (15:3-15:6). Complete stone clearance (seconds) was calculated and impact and frequency were adjusted and repeated N = 3. Intra renal pressure (IRP) was then measured in a porcine kidney model.

resultsStone phantoms with physical properties similar to struvite were cleared best with 100% impact and frequency of 12 Hz. Both uric acid stone phantoms and calcium phosphate stone phantoms were cleared most efficiently with an impact of 30% and a frequency of 4 Hz. The mean time to clear uric acid stone phantoms was 83 s versus 217 s for calcium phosphate stone phantoms. Similarly, for calcium oxalate stone phantoms, an impact of 30% and a frequency of 4 Hz was associated with the fastest clearance time, mean 204 s. However, the differences between 4, 8 and 12 Hz were not statistically significant. At a suction level of 60% or higher, IRP became negative.

conclusionThese results indicate that stone phantoms of hard kidney stones are cleared more efficiently at lower impact and frequency settings. With regard to suction, a setting of ≤ 50% appears to be the optimal setting.

Indexed as

Kidney CalculiNephrostomy, PercutaneousAnimalsCalcium OxalatePowdersStruviteSwineUric AcidWaterCalcium OxalatePowdersStruviteUric AcidWaterBegostoneNephrolithotomyPercutaneousSettingsTrilogy

Identifiers

PMID36001137
PMCPMC9512712
OpenAlexW4293171257

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.